# The Procter & Gamble (PG) — News

PG · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/pg/news

## Recent headlines

- [Moody's Ratings affirms Procter & Gamble's AA3/P-1 ratings; outlook changed to positive](https://www.ainvest.com/news/moody-ratings-affirms-procter-gamble-aa3-1-ratings-outlook-changed-positive-2609) — AInvest Wire, Sep 2, 2026
  Moody’s Investors Service has affirmed Procter & Gamble’s (P&G) long-term credit rating of AA3 and short-term rating of P-1, with outlook revised to positive from stable. The upgrade in outlook reflects Moody’s assessment of P&G’s strong market position, consistent cash flow generation, and ongoing…
- [P&G: Bernstein raises target price to $149 from $148](https://www.ainvest.com/news/bernstein-raises-target-price-149-148-2608) — AInvest Wire, Aug 24, 2026
  Bernstein SocGen Group has adjusted its price target for Procter & Gamble Co. (NYSE:PG), raising it to $149 from $148, while maintaining a Market Perform rating. The firm cited the company’s low single-digit organic sales growth, driven by its Beauty segment, as a key factor in the revised outlook.…
- [Diageo: Most recently, Keith served as CEO of Procter & Gamble's beauty business](https://www.ainvest.com/news/diageo-keith-served-ceo-procter-gamble-beauty-business-2608) — AInvest Wire, Aug 18, 2026
- [P&G: Argus Research cuts to hold from buy](https://www.ainvest.com/news/argus-research-cuts-hold-buy-2608) — AInvest Wire, Aug 7, 2026
  Argus Research has downgraded its recommendation for Procter & Gamble (NYSE: PG) from "Buy" to "Hold," citing evolving market dynamics and a reassessment of the company’s near-term growth prospects. The move reflects a broader recalibration of expectations for the consumer goods giant, particularly…
- [P&G Health 1Q net income 961.5M rupees, +45% y/y](https://www.ainvest.com/news/health-1q-net-income-961-5m-rupees-45-2608) — AInvest Wire, Aug 6, 2026
  Procter & Gamble (P&G) reported strong financial performance for fiscal year 2023, with organic sales growth of 7% and core EPS increasing by 2% despite significant cost pressures. The company's Health segment, which includes Personal Health Care and Oral Care, demonstrated robust growth, with…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).